Once-daily dose of budesonide aqueous nasal spray 128 g is efficacious primary treatment with rapid onset in nasal polyps.

被引：0

作者：

Jankowski, R ^{[1
]}

Bonfils, P ^{[1
]}

Castillo, L ^{[1
]}

Gilain, L ^{[1
]}

Prades, JM ^{[1
]}

Strunski, V ^{[1
]}

机构：

[1] Hop Cent, Nancy, France

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

635

引用

页码：S166 / S166

页数：1

共 43 条

[21] Comparison of once-daily triamcinolone acetonide aqueous nasal spray and twice-daily beconase AQ(R) for the treatment of seasonal allergic rhinitis due to ragweed.
LaForce, C
Hampel, F
Kiechel, F
Lumry, W
Murray, JJ
Furst, JA
Simpson, B
Smith, JA
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 1002 - 1002
[22] Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours
Fokkens, WJ
Cserháti, E
dos Santos, JML
Praca, F
van Zanten, M
Schade, A
Simon, G
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (03) : 279 - 284
[23] Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis.
Smith, JA
Schenkel, EJ
Gross, G
Jacobson, K
Kobayashi, R
Settipane, G
Feiss, G
Furst, JA
Simpson, B
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 60 - 60
[24] Once-daily mometasone furoate nasal spray provides continuous improvement of nasal congestion throughout the treatment period in subjects with moderate-to-severe seasonal allergic rhinitis
Nayak, A.
Anolik, R.
Shekar, T.
Teper, A.
ALLERGY, 2010, 65 : 280 - 280
[25] Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol 320 μg Provides 24-Hour Nasal Symptom Relief in Patients with Seasonal Allergic Rhinitis
Finn, Albert F., Jr.
Prenner, Bruce
Nathan, Robert A.
Ruff, Michael
Kelley, Leith
Tantry, Sudeesh
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB114 - AB114
[26] Comparison of once-daily treatment with mometasone furoate (Nasonex(TM)) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis.
Day, J
Nolop, K
Lutsky, BN
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1792 - 1792
[27] Concomitant once-daily administration of mometasone furoate nasal spray with one spray and three sprays of oxymetazoline is effective for the treatment of subjects with seasonal allergic rhinitis
Berger, W.
Corren, J.
Shekar, T.
Ariel, T.
ALLERGY, 2010, 65 : 154 - 154
[28] Pharmacoeconomic benefits of fluticasone propionate aqueous nasal spray 200 mu g once daily in perennial allergic rhinitis.
Adams, JE
Blackman, NJM
Tesarowski, DB
Stepner, N
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 59 - 59
[29] Once-daily mometasone furoate aqueous nasal spray (Nasonex(TM)) in seasonal allergic rhinitis: An active- and placebo-controlled study
Hebert, JR
Nolop, K
Lutsky, BN
ALLERGY, 1996, 51 (08) : 569 - 576
[30] Once-daily administration of Rhinocort® (budesonide) Aqua nasal spray versus twice-daily administration of Beconase AQ® (beclomethasone dipropionate) in the long-term treatment of adults with perennial allergic rhinitis.
LaForce, C
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S249 - S249

← 1 2 3 4 5 →